NO20061354L - Fremgangsmater og sammensetninger for oral administrering av prodroger av protonpumpe inhibitatorer - Google Patents

Fremgangsmater og sammensetninger for oral administrering av prodroger av protonpumpe inhibitatorer

Info

Publication number
NO20061354L
NO20061354L NO20061354A NO20061354A NO20061354L NO 20061354 L NO20061354 L NO 20061354L NO 20061354 A NO20061354 A NO 20061354A NO 20061354 A NO20061354 A NO 20061354A NO 20061354 L NO20061354 L NO 20061354L
Authority
NO
Norway
Prior art keywords
methods
proton pump
pump inhibitor
compositions
oral administration
Prior art date
Application number
NO20061354A
Other languages
English (en)
Inventor
Devin Franklin Welty
Diane D Tang-Liu
Jie Shen
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of NO20061354L publication Critical patent/NO20061354L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Orale doseringsformer, fremgangsmåter for behandling av sykdommer eller ugunstige tilstander, og fremgangsmåter for hemming av magesyresekresjon relatert til prodroger av en protonpumpe inhibitor er angitt heri. Visse utførelsesformer angår membranpermeabiliteten av protonpumpe inhibitoren og/eller membranpermeabiliteten av prodrogen. Andre utførelsesformer angår prodroger omfattende en funksjonell syregruppe og en sulfonylgruppe. I andre utførelsesformer er prodrogen en karboksylsyre som omfatter en fenylsulfonylgruppe. Andre utførelsesformer angår pH av doseringsformer og doseringsformer omfattende salter av funksjonelle syregrupper.
NO20061354A 2003-10-03 2006-03-24 Fremgangsmater og sammensetninger for oral administrering av prodroger av protonpumpe inhibitatorer NO20061354L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50835603P 2003-10-03 2003-10-03
US51388003P 2003-10-22 2003-10-22
PCT/US2004/032099 WO2005034951A1 (en) 2003-10-03 2004-10-01 Methods and compositions for the oral administration of prodrugs of proton pump inhibitors

Publications (1)

Publication Number Publication Date
NO20061354L true NO20061354L (no) 2006-05-03

Family

ID=34437281

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061354A NO20061354L (no) 2003-10-03 2006-03-24 Fremgangsmater og sammensetninger for oral administrering av prodroger av protonpumpe inhibitatorer

Country Status (13)

Country Link
US (1) US20050075371A1 (no)
EP (1) EP1670467A1 (no)
JP (1) JP2007518700A (no)
KR (1) KR20060082082A (no)
AR (1) AR045857A1 (no)
AU (1) AU2004279378A1 (no)
BR (1) BRPI0415044A (no)
CA (1) CA2540977A1 (no)
IL (1) IL174265A0 (no)
MX (1) MXPA06003461A (no)
NO (1) NO20061354L (no)
TW (1) TW200522956A (no)
WO (1) WO2005034951A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005216863A1 (en) * 2004-02-18 2005-09-09 Allergan, Inc. Methods and compositions for the intravenous administration of compounds related to proton pump inhibitors
JP2007523163A (ja) * 2004-02-18 2007-08-16 アラーガン、インコーポレイテッド プロトンポンプインヒビターのプロドラッグの投与のための方法および組成物
WO2007081871A1 (en) * 2006-01-10 2007-07-19 Allergan, Inc. Therapeutic salt compositions of sulfonyl ester prodrugs of proton pump inhibitors and methods for their preparation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
WO1991019712A1 (en) * 1990-06-20 1991-12-26 Aktiebolaget Astra Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
TR200100431T2 (tr) * 1998-08-10 2001-06-21 Partnership Of Michael E. Garst, George Sachs & Jai Moo Proton pompalama önleyici ilaçlar
DE60304726T2 (de) * 2002-07-19 2007-08-09 Winston Pharmaceuticals Llc, Newport Beach Benzimidazolderivative und ihre verwendung als prodrugs für protonenpumpenhemmer
AU2004264401A1 (en) * 2003-07-15 2005-02-24 Allergan, Inc. Process for preparing isomerically pure prodrugs of proton pump inhibitors

Also Published As

Publication number Publication date
KR20060082082A (ko) 2006-07-14
US20050075371A1 (en) 2005-04-07
BRPI0415044A (pt) 2006-12-12
WO2005034951A1 (en) 2005-04-21
EP1670467A1 (en) 2006-06-21
AR045857A1 (es) 2005-11-16
IL174265A0 (en) 2006-08-01
MXPA06003461A (es) 2006-06-05
JP2007518700A (ja) 2007-07-12
AU2004279378A1 (en) 2005-04-21
CA2540977A1 (en) 2005-04-21
TW200522956A (en) 2005-07-16

Similar Documents

Publication Publication Date Title
CA2338311A1 (en) Prodrugs of the pyridyl methyl sulfinyl benzimidazoles
JOP20210301A1 (ar) بيرولات ثلاثية الحلقة مكثفة كمُعدِّلات مضاد تريبسين ألفا-1
NO20055370L (no) Alfa-substituert karboksylsyre som PPAR modulatorer
IS2696B (is) Setin 2-amínótetralín fyrir meðhöndlunina á geðdeyfð
NO20061432L (no) N3 alkylerte benzimidazolederivater som MEK-inhibitorer
CY1112831T1 (el) Παραγωγα αζαβιρηενυlαμινοβενζοιc acid σαν παραγοντες καταστολης dhodh
NO20092033L (no) Nye forbindelser
DK1565471T3 (da) Quionolinylpyrazoler
BRPI0418245B8 (pt) composto derivado de nitróxi de prostaglandina, processo para preparar dito composto, composição farmacêutica compreendendo dito composto e usos destes
NO20054260L (no) Disepergebar formulering av en anti-inflammatorisk forbindelse
SG2013013339A (en) N3 alkylated benzimidazole derivatives as mek inhibitors
WO2023078333A8 (zh) 一种取代的苯丙酸衍生物及其用途
NO20083836L (no) N-hydroksyakrylamidforbindelser
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
PE20050822A1 (es) Derivados de florfenicol con mejor solubilidad en agua
SE0202429D0 (sv) Novel Compounds
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
NO20040074L (no) Fremgangsmåte for fremstilling av benzimidazoltype forbindelser
NO20080697L (no) Modifiserte farmasoytiske doseringsformer for frigivelse av syklooksygenase enzyminhibitor
NO20050801L (no) Prodrug av protonpumpe inhibitorer
HRP20080027T3 (hr) 4-hidroksi-4-metil-piperidin-1-karboksilna kiselina (4-metoksi-7-morfolin-4-il-benzotiazol-2-il)-amid
NO20060114L (no) Naftylenderivater som cytokrom P450-inhibitorer
NO20050667L (no) N-substituerte-1H-indol-5-propionsyreforbindelser som PPAR agonister nyttige for behandling av diabetes
NO20061354L (no) Fremgangsmater og sammensetninger for oral administrering av prodroger av protonpumpe inhibitatorer
WO2008002567A3 (en) Methods of treating conditions by sustained release administration of benzimidazole derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application